# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA698858 | F | Ability to suppress interleukin-2 production was determined after 2.5 hours of oral administration in mice | 3 | ALA1146742 | organism-based format | Scientific Literature | ||
2. | ALA698859 | F | Effective concentration to suppress interleukin-2 production was measured after 2.5 hours of oral administration in mice | 4 | ALA1146742 | organism-based format | Scientific Literature | ||
3. | ALA698860 | F | Effective concentration to suppress interleukin-2 production was measured after 2.5 hours of oral administration in mice | 4 | ALA1146742 | organism-based format | Scientific Literature | ||
4. | ALA698861 | F | Percent inhibition of interleukin-2 production by compound was measured after 18 hours of oral administration in mice | 4 | ALA1146742 | organism-based format | Scientific Literature | ||
5. | ALA698586 | F | Percent inhibition of interleukin-2 production by compound was measured after 8 hours of oral administration in mice | 4 | ALA1146742 | organism-based format | Scientific Literature | ||
6. | ALA698587 | F | Tested in vitro for inhibition of Interleukin-2 (IL-2) release; 100 times less active than cyclosporin A | 3 | ALA1128785 | assay format | Scientific Literature | ||
7. | ALA698588 | F | Tested in vitro for inhibition of Interleukin-2 (IL-2) release; 2-3 times less active than compound 1 | 2 | ALA1128785 | assay format | Scientific Literature | ||
8. | ALA698589 | F | Tested in vitro for inhibition of Interleukin-2 (IL-2) release; Active | 1 | ALA1128785 | assay format | Scientific Literature | ||
9. | ALA698590 | F | The compound was evaluated in vitro for the immunosuppressive activity in interleukin-2 by interleukin-2 reporter gene assay (IL2-RGA) | 4 | ALA1128525 | assay format | Scientific Literature |